Cefazolin Should Be Used for Uncomplicated Leg Cellulitis
For uncomplicated leg cellulitis in adults, cefazolin is the appropriate first-line choice, not cefepime. Cefepime is unnecessarily broad-spectrum for this indication and should be reserved for more complex scenarios.
Guideline-Based Recommendation
The 2014 IDSA guidelines clearly stratify cellulitis treatment by severity 1:
- Mild cellulitis without systemic signs: Use an antimicrobial active against streptococci (the primary pathogen)
- Moderate cellulitis with systemic signs: Many clinicians include MSSA coverage
- Severe cellulitis: Reserve broad-spectrum agents like vancomycin plus piperacillin-tazobactam or carbapenems for severely compromised patients
Cefazolin fits perfectly as first-line therapy because it provides excellent coverage against both streptococci (the most common cause) and methicillin-susceptible Staphylococcus aureus (MSSA), which together account for the vast majority of uncomplicated cellulitis cases 1.
Why Not Cefepime?
Cefepime is a fourth-generation cephalosporin with broad gram-negative coverage, including Pseudomonas aeruginosa. This spectrum is:
- Unnecessarily broad for typical leg cellulitis
- Not indicated unless specific risk factors exist (penetrating trauma, injection drug use, immunocompromise, or documented resistant organisms) 1
- Associated with neurotoxicity risks, particularly in elderly patients or those with renal impairment—including encephalopathy, myoclonus, and seizures 2
Clinical Evidence Supporting Cefazolin
Recent research confirms cefazolin's effectiveness:
- A 2025 study demonstrated that even in obese patients (≥120 kg), cefazolin 3g showed a 63.7% probability of better outcomes compared to standard dosing 3
- A 2002 RCT showed cefazolin 2g IV daily plus probenecid achieved 86% clinical cure rates for moderate-to-severe cellulitis, comparable to ceftriaxone 4
- Multiple studies confirm cefazolin's efficacy for outpatient parenteral therapy of cellulitis 5, 6
Practical Dosing Algorithm
Standard dosing:
- Cefazolin 1-2g IV every 8 hours for hospitalized patients
- For outpatient parenteral therapy: Cefazolin 2g IV once daily plus probenecid 1g PO once daily
Special considerations:
- Patients ≥120 kg: Consider cefazolin 3g per dose 3
- Renal impairment: Adjust based on creatinine clearance (cefazolin is renally cleared but has a better safety profile than cefepime)
- Treatment duration: 5 days minimum, extend if not improved 1
When to Consider Broader Coverage (Not Routine Cefepime)
Reserve broader-spectrum antibiotics only when:
- Penetrating trauma or injection drug use
- Purulent drainage suggesting MRSA
- Systemic inflammatory response syndrome (SIRS)
- Documented MRSA colonization
- Immunocompromise or neutropenia
In these cases, vancomycin (for MRSA coverage) is more appropriate than cefepime 1.
Critical Pitfalls to Avoid
- Don't use cefepime reflexively for simple cellulitis—this promotes antimicrobial resistance and exposes patients to unnecessary neurotoxicity risk
- Don't forget to examine interdigital toe spaces—treating tinea pedis reduces recurrence 1
- Don't overlook renal function—both antibiotics require dose adjustment, but cefepime carries higher neurotoxicity risk in renal impairment 2
- Don't culture routinely—blood and tissue cultures are not recommended for uncomplicated cellulitis 1
The evidence overwhelmingly supports cefazolin as the appropriate first-line agent for uncomplicated leg cellulitis, reserving cefepime for documented resistant organisms or specific high-risk scenarios.